Emergent BioSolutions Inc. (74) | Business Finance (44)

Browse by Subcategory

Recent Contracts

Modification No. 6, effective March 24, 2021, to Task Order 75A50120F33007 (Filed With SEC on April 30, 2021)
Global Form of Restricted Stock Unit Award Agreement (Filed With SEC on February 19, 2021)
Purchase Agreement, dated as of August 4, 2020, by and among the Company, the subsidiaries of the Company named therein as guarantors, and Wells Fargo Securities, LLC, as... (Filed With SEC on August 7, 2020)
Second Amendment to Amended and Restated Credit Agreement, dated August 7, 2020 (Filed With SEC on August 7, 2020)
Indenture, dated as of August 7, 2020, by and among the Company, certain subsidiaries of the Company and U.S. Bank National Association, as trustee (Filed With SEC on August 7, 2020)
Modification No. 5, effective February 22, 2021, to Task Order 75A50120F33007 (Filed With SEC on April 30, 2021)
Modification No. 2, effective, October 28, 2020 to the ACAM 2000 Contract (Filed With SEC on February 19, 2021)
Modification No. 2 (Filed With SEC on February 19, 2021)
Modification No. 23, effective September 30, 2020, to the CDC BioThrax Procurement Contract (Filed With SEC on February 19, 2021)
Modification No. 2 (Filed With SEC on February 19, 2021)
Modification No. 2, effective September 18, 2020, to Task Order 75A50120F33007 (Filed With SEC on February 19, 2021)
Modification No. 3, effective October 7, 2020, to Task Order 75A50120F33007 (Filed With SEC on February 19, 2021)
Modification No. 2, effective November 17, 2020, to Task Order 75A50120F33008 (Filed With SEC on February 19, 2021)
Modification No. 26, effective November 2, 2020 to the BARDA ADM Contract (Filed With SEC on February 19, 2021)
Modification No. 1, effective August 24, 2020, to (Filed With SEC on November 6, 2020)
Modification No. 25, effective September 25, 2020, to the BARDA ADM Contract (Filed With SEC on November 6, 2020)
Modification No. 24, effective August 28, 2020, to the BARDA ADM Contract (Filed With SEC on November 6, 2020)
Modification No. 23, effective July 22, 2020, to the BARDA ADM Contract (Filed With SEC on November 6, 2020)
Modification No. 22, effective June 12, 2020, to the BARDA ADM Contract (Filed With SEC on November 6, 2020)
Purchase Agreement, dated as of August 4, 2020, by and among the Company, the subsidiaries of the Company named therein as guarantors, and Wells Fargo Securities, LLC, as... (Filed With SEC on August 7, 2020)
Second Amendment to Amended and Restated Credit Agreement, dated August 7, 2020 (Filed With SEC on August 7, 2020)
Indenture, dated as of August 7, 2020, by and among the Company, certain subsidiaries of the Company and U.S. Bank National Association, as trustee (Filed With SEC on August 7, 2020)
Modification No. 20, effective, May 26, 2020, to the BARDA ADM Contract (Filed With SEC on July 31, 2020)
Modification No. 19, effective, May 25, 2020, to the BARDA ADM Contract (Filed With SEC on July 31, 2020)
Modification #No. 5, effective April 10, 2020, to the BARDA AV7909 Contract (Filed With SEC on May 1, 2020)
Modification No. 20, effective January 7, 2020, to the CDC BioThrax Procurement Contract (Filed With SEC on February 25, 2020)
Modification No. 19, effective January 6, 2020, to the CDC BioThrax Procurement Contract (Filed With SEC on February 25, 2020)
Modification No. 18, effective September 11, 2019, to the CDC BioThrax Procurement Contract (Filed With SEC on February 25, 2020)
Global Form of Non-Qualified Stock Option Agreement (Filed With SEC on February 25, 2020)
Global Form of Restricted Stock Unit Award Agreement (Filed With SEC on February 25, 2020)
First Amendment, dated June 27, 2019, to Amended and Restated Credit Agreement, dated October 15, 2018, by and among Emergent BioSolutions Inc., the lenders party thereto from... (Filed With SEC on August 2, 2019)
Modification No. 17, effective June 13, 2019, to the Solicitation/Contract/Order for Commercial Items, effective December 8, 2016, from the Centers for Disease Control and... (Filed With SEC on August 2, 2019)
EMERGENT BIOSOLUTIONS INC. Form of Director Restricted Stock Unit Agreement (Filed With SEC on February 22, 2019)
Emergent BioSolutions Inc. Form of Restricted Stock Unit Award Agreement Canadian Participant (Filed With SEC on February 22, 2019)
Emergent BioSolutions Inc. Non-Qualified Stock Option Award Agreement (Filed With SEC on February 22, 2019)
Emergent BioSolutions Inc. Form of Restricted Stock Unit Award Agreement (Filed With SEC on February 22, 2019)
Emergent BioSolutions Inc. Non-Qualified Stock Option Award Agreement Canadian Participant (Filed With SEC on February 22, 2019)
Emergent BioSolutions Inc. Form of Restricted Stock Unit Award Agreement Irish Participant (Filed With SEC on February 22, 2019)
Emergent BioSolutions Inc. Non-Qualified UK Stock Option Award Agreement UK Participant (Filed With SEC on February 22, 2019)
Emergent BioSolutions Inc. Form of UK Restricted Stock Unit Award Agreement UK Participant (Filed With SEC on February 22, 2019)
Emergent BioSolutions Inc. Non-Qualified Stock Option Award Agreement Swiss Participant (Filed With SEC on February 22, 2019)
Emergent BioSolutions Inc. Form of Restricted Stock Unit Award Agreement Swiss Participant (Filed With SEC on February 22, 2019)
Emergent BioSolutions Inc. Non-Qualified Stock Option Award Agreement Irish Participant (Filed With SEC on February 22, 2019)
Emergent BioSolutions Inc. Form of Director Nonstatutory Stock Option Agreement (Filed With SEC on February 22, 2019)